Evidence review · Separating cause from appearance
Filler migration: what the evidence actually says
Migration is real, and it is also badly overstated. In the peer-reviewed literature, gel genuinely travelling away from where it was placed appears almost only as isolated case reports — there is no cohort study establishing how common it is. Meanwhile the things that produce the same appearance, months or years later, have been studied in thousands of patients: too much product, placement in the wrong plane, and delayed inflammatory reactions. Most of what gets called migration online is technique, presenting late.
From the consulting room
"When someone comes in with a shelf above the lip border, the honest answer is almost never that the product wandered. It is that too much of it went in, or it went in too shallow, and the tissue has spent a year telling the truth about that. Blaming migration is comfortable, because it blames the syringe instead of the decision."
— Dr Ahmed Haq, GMC 6078057, Cosmedocs, Harley Street
What the literature contains — and what it does not
A 2023 narrative review of facial filler migration concluded that reported cases are a heterogeneous group, and that true migration must be separated from over-volumisation, wrong-plane or superficial placement, and simple diffusion within one tissue plane1. An earlier periocular series of three patients was titled, tellingly, a number of mechanisms to consider, and framed migration as multifactorial and poorly proven2. Individual case reports do exist, including one patient presenting five and a half years after treatment with eyelid swelling that mimicked primary eyelid disease3. Case reports demonstrate that something can happen. They cannot tell you how often.
What has been counted properly
Delayed-onset nodules have. A single-clinic retrospective study followed 2,139 patients treated with one family of hyaluronic acid products and characterised delayed nodules as a definable, treatable complication linked to product chemistry4. Reviews now propose formal diagnostic algorithms for late lumps — infection or biofilm, foreign-body granuloma, delayed inflammatory reaction, or simply persistent gel in the wrong place — specifically to stop all of them being labelled migration5. Subclinical bacterial biofilm is a recognised driver of late swelling at the original site6.
| What people see | Likely cause | Evidence base |
|---|---|---|
| Gel found in a different region entirely | True migration | Case reports and series of one to three patients only |
| A shelf or ridge appearing over months | Over-volumisation, or product too superficial for the plane | Reviews of technique-related complications |
| Sudden swelling months or years later | Delayed inflammatory reaction, or biofilm | Cohort of 2,139 patients; mechanistic biofilm research |
| The area looking softly larger over time | Diffusion within the plane, or water uptake by the gel | Ultrasound follow-up and three-dimensional MRI |
Why the distinction is not pedantry
Because it decides the treatment. Misplaced gel is dissolved. An inflammatory reaction is treated medically. A biofilm needs a different approach again. Calling everything migration leads to the wrong intervention, and it lets the actual lesson — restraint, plane discipline, product choice — slip away unlearned. High-resolution ultrasound is what settles it: it locates the deposit, identifies its plane, and distinguishes inert gel from inflamed tissue by margins and blood flow7.
Volume is the hidden variable
Tissue has a limit. Filling to the edge of that limit looks acceptable on the day and reveals itself a year later. Treating in small amounts across sessions is not caution for its own sake — it is how you avoid the appearance everyone calls migration.
Late swelling deserves a diagnosis
New swelling months after treatment is not something to dissolve on instinct. It needs assessment, often imaging, and a named cause before anything is injected — or removed.
What this means for you
If you are worried about a result, the useful question is not "has it migrated?" but "what is there, where is it, and is it irritated?" That is answerable. It is also the reason we treat conservatively and keep to reversible material — the companion piece on how long fillers really last on MRI explains why longevity makes plane discipline matter even more. If existing product needs to come out, dissolving hyaluronic acid is straightforward in experienced hands.
Frequently asked questions
Is filler migration real?
Genuine migration — gel physically travelling away from where it was placed — does exist, but in the peer-reviewed literature it appears almost entirely as single case reports and very small series, usually around the eye area. There is no large study establishing how often it happens. That tells you something important: it is rare enough that nobody has been able to count it properly, while the word itself has become extremely common online.
Why do lips or under-eyes look swollen months after filler?
Usually for reasons other than migration. The three commonest explanations are too much product for the space, placement that was too superficial or in the wrong plane, and a delayed inflammatory reaction or low-grade biofilm at the original site. Delayed-onset nodules have been studied in cohorts of thousands of patients and are a recognised, definable complication. Late swelling is therefore far more likely to be one of those than the gel going for a walk.
What is the difference between migration and bad technique?
Migration means the material has moved to a different anatomical location. Bad technique means it was never in the right location. A narrative review of facial filler migration made exactly this point: reported cases are a mixed group, and many are better explained by overcorrection, superficial placement, or choosing a thin, spreadable product for a mobile plane. The appearance is similar. The cause, and the lesson, are not.
Can filler spread without migrating?
Yes, and this is worth understanding. High-frequency ultrasound follow-up shows a deposit gradually diffusing within its own tissue plane over time, and three-dimensional MRI work shows hyaluronic acid taking on water and measuring larger than the volume injected. Both are changes happening in place. Neither is the product travelling to a new region of the face.
How is real migration diagnosed?
By imaging and history together, not by looking at a photograph. High-resolution ultrasound can locate a deposit, show which plane it occupies, and distinguish inert gel from an inflammatory or infective nodule by its margins and the blood flow around it. That distinction matters because the treatments are completely different: dissolving misplaced gel, versus treating an inflammatory reaction or infection.
How do you reduce the risk in the first place?
Anatomically and conservatively. Place product in the plane it was designed for, choose a firmer product for structural support and a softer one for delicate tissue, treat in small amounts across sessions rather than filling to the limit in one, and stop when the face looks rested rather than full. Most of what the internet calls migration is a volume decision made years earlier.
Your consultation begins here
Worried about a result?
Bring it to a doctor who will assess before acting — including results from elsewhere. We will tell you what we think is actually there, and whether the honest answer is to do nothing.
Book a consultationReferences
- Wollina U, Goldman A. Filler migration after facial injection — a narrative review. Cosmetics. 2023;10(4):115. View source
- Jordan DR, Stoica B. Filler migration: a number of mechanisms to consider. Ophthalmic Plast Reconstr Surg. 2015;31(4):257–262. View source
- Delayed migration of soft tissue fillers in the periocular area masquerading as eyelid and orbital pathology. BMJ Case Rep. 2021. View source
- Rivers JK, et al. Incidence and treatment of delayed-onset nodules after VYC filler injections in 2,139 patients at a single clinic. J Cosmet Dermatol. 2022;21(6):2379–2386. View source
- Goodman G, McDonald C, Lim A, et al. Making sense of late tissue nodules associated with hyaluronic acid injections. Aesthet Surg J. 2023. View source
- Biofilm formation is a risk factor for late and delayed complications of filler injection. Front Microbiol. 2024;14:1297948. View source
- The use of high-frequency ultrasonography for the diagnosis of palpable nodules after the administration of dermal fillers. J Ultrason. 2020;20(83):e248–e253. View source
Note on evidence quality: the migration literature consists of narrative reviews and case reports. Any percentage figure quoted for how often migration occurs is expert opinion, not measured data.
Responsibility statement
This article is general information for adults and is not a substitute for individual medical advice. If you have a concern about a previous treatment, please arrange assessment with a qualified doctor. Written by Dr Ahmed Haq, GMC 6078057, and reviewed by the Cosmedocs Clinical Team.